Developmental and stem cell biology's bright future.

The next 50 years of developmental biology will illuminate exciting new discoveries but are also poised to provide solutions to important problems society faces. Ten scientists whose work intersects with developmental biology in various capacities tell us about their vision for the future.
Competing Interests: Declaration of interests J.L. has filed patents related to printing vascularized human tissues and organs from stem cell-derived multicellular building blocks. She is a member of the scientific advisory board of Trestle Biotherapeutics, Inc. (a startup company). Trestle has also licensed IP on kidney bioprinting from Harvard, in which the author is listed as an inventor. M.S. has filed patents for reducing aneuploidy in eggs. J.H.H. was granted (through Yeda–Weizmann Institute of Science) patents relevant to the findings and technologies discussed herein (naive and naive-like pluripotency and mouse and human structure-complete embryo models [SEMs]). J.H.H. is a co-founder and chief scientific advisor of Renewal Bio, which has licensed technologies mentioned above. M.Z.G. is an inventor on patents of stem cell-derived models of human and mouse embryos. S.M. is a founder and supervisory and scientific board member of HeartBeat.bio, an IMBA spin-off, based on submitted cardioid (2020) and multi-chamber cardioid (2022) patent applications.
(Copyright © 2024. Published by Elsevier Inc.)